Cargando…

Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach

Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries nee...

Descripción completa

Detalles Bibliográficos
Autores principales: Trad, Fouad, El Falou, Salah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131986/
https://www.ncbi.nlm.nih.gov/pubmed/35637643
http://dx.doi.org/10.1007/s42979-022-01199-6
_version_ 1784713288701968384
author Trad, Fouad
El Falou, Salah
author_facet Trad, Fouad
El Falou, Salah
author_sort Trad, Fouad
collection PubMed
description Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries need a way to test the effect of different distribution strategies before applying them. But how can they do this? To assist countries with this task, we built an agent-based model that runs on top of the Monte Carlo algorithm. This model simulates the spread of COVID-19 in a country where we can apply different NPIs at different times, and we can supply different kinds of vaccines using different strategies. In this study, we tested the outcomes of four vaccination strategies: older first, younger first, a mixed strategy, and a random strategy. We simulated these strategies in two different countries: France and Colombia. Then, we performed a comparative analysis to find which strategy might be the best for each country. Our results show that what is good for a country is not necessarily the best for the other one. Therefore, we proved that a vaccination strategy should be adapted to the structure of the population we are vaccinating. The system we built helps countries in this direction by allowing them to test the outcomes of their strategies before applying them in real life to select the one that minimizes human losses (deaths and infections).
format Online
Article
Text
id pubmed-9131986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-91319862022-05-26 Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach Trad, Fouad El Falou, Salah SN Comput Sci Original Research Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries need a way to test the effect of different distribution strategies before applying them. But how can they do this? To assist countries with this task, we built an agent-based model that runs on top of the Monte Carlo algorithm. This model simulates the spread of COVID-19 in a country where we can apply different NPIs at different times, and we can supply different kinds of vaccines using different strategies. In this study, we tested the outcomes of four vaccination strategies: older first, younger first, a mixed strategy, and a random strategy. We simulated these strategies in two different countries: France and Colombia. Then, we performed a comparative analysis to find which strategy might be the best for each country. Our results show that what is good for a country is not necessarily the best for the other one. Therefore, we proved that a vaccination strategy should be adapted to the structure of the population we are vaccinating. The system we built helps countries in this direction by allowing them to test the outcomes of their strategies before applying them in real life to select the one that minimizes human losses (deaths and infections). Springer Nature Singapore 2022-05-25 2022 /pmc/articles/PMC9131986/ /pubmed/35637643 http://dx.doi.org/10.1007/s42979-022-01199-6 Text en © The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Trad, Fouad
El Falou, Salah
Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach
title Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach
title_full Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach
title_fullStr Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach
title_full_unstemmed Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach
title_short Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach
title_sort testing different covid-19 vaccination strategies using an agent-based modeling approach
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131986/
https://www.ncbi.nlm.nih.gov/pubmed/35637643
http://dx.doi.org/10.1007/s42979-022-01199-6
work_keys_str_mv AT tradfouad testingdifferentcovid19vaccinationstrategiesusinganagentbasedmodelingapproach
AT elfalousalah testingdifferentcovid19vaccinationstrategiesusinganagentbasedmodelingapproach